Bridger Management 13F, Q3 2024

Roberto Mignone · quarter ending 30 September 2024 · filed 14 November 2024 · SEC CIK 1166309

$199.92M
Filed US book
29
Positions
11.3%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed.

Largest positions, Q3 2024

The 25 largest of 29 positions. Weights are against the whole filed book. Changes are in shares held, against the Q2 2024 filing.

CompanyTickerValue% of bookvs Q2 2024
UBER TECHNOLOGIES INCUBER$22.66M11.3%unchanged
MORGAN STANLEYMS$19.57M9.8%unchanged
VERTEX PHARMACEUTICALS INCVRTX$19.09M9.6%unchanged
TEVA PHARMACEUTICAL INDS LTDTEVA$17.68M8.8%unchanged
ALNYLAM PHARMACEUTICALS INCALNY$10.18M5.1%unchanged
PFIZER INCPFE$10.14M5.1%unchanged
BAUSCH PLUS LOMB CORPBLCO$9.77M4.9%unchanged
WYNN RESORTS LTDWYNN$9.61M4.8%new
OSCAR HEALTH INCOSCR$8.78M4.4%+332% shares
VANECK ETF TRUSTGDX$7.72M3.9%new
MELCO RESORTS AND ENTMNT LTDMLCO$7.66M3.8%unchanged
BRISTOL-MYERS SQUIBB COBMY$7.54M3.8%new
BATH & BODY WORKS INCBBWI$7.08M3.5%unchanged
CAESARS ENTERTAINMENT INC NECZR$6.16M3.1%unchanged
GERON CORPGERN$6.07M3.0%unchanged
XENON PHARMACEUTICALS INCXENE$5.78M2.9%unchanged
SPRINGWORKS THERAPEUTICS INC$4.63M2.3%unchanged
ISHARES BITCOIN TRUST ETFIBIT$3.91M2.0%new
ALPHABET INCGOOGL$2.31M1.1%unchanged
QUANTERIX CORPQTRX$2.01M1.0%unchanged
EDGEWISE THERAPEUTICS INCEWTX$1.99M1.0%new
MICROSOFT CORPMSFT$1.82M0.9%unchanged
CATALYST PHARMACEUTICALS INCCPRX$1.80M0.9%-51% shares
SAVARA INCSVRA$1.60M0.8%new
TOAST INCTOST$1.49M0.8%unchanged

What changed since Q2 2024

Against the Q2 2024 filing, Bridger Management opened 6 new positions, added to 1, trimmed 2, left 20 unchanged and exited 5. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

Exited

  • LLYwas $22.37M
  • TSMwas $9.01M
  • DXCMwas $3.28M
  • HILLEVAX INCwas $2.03M
  • UNIQURE NVwas $1.62M

Added to

Trimmed

  • CPRX-51%$1.80M
  • 430-42%$1.19M

Other quarters

Source: SEC Form 13F-HR, accession 0001166309-24-000020, filed by BRIDGER MANAGEMENT, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.